Salarius Pharmaceuticals
SLRX
SLRX
11 hedge funds and large institutions have $321K invested in Salarius Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$163K | |
| 2 | +$15.6K | |
| 3 | +$12.3K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$1.49K |
| 5 |
Renaissance Technologies
New York
|
+$725 |
Top Sellers
| 1 | -$19.8K | |
| 2 | -$928 | |
| 3 | -$713 | |
| 4 |
BlackRock
New York
|
-$90 |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$90 |